Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2024 Filed Feb 13, 2024 21:46 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 3,145 | $420.24 | $1,321,654.80 |
DisclosureSEC source: 0000875320-24-000039 · wk-form4_1707860733.xml · nonDerivative · entry 2 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,588 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1, which was entered into on 5/10/2023. Read SEC document |
| February 12, 2024 Filed Feb 13, 2024 21:51 UTC |
Arbuckle Stuart AEVP, COO
|
SaleCommon Stock | 4,295 | $420.24 | $1,804,930.80 |
DisclosureSEC source: 0000875320-24-000043 · wk-form4_1707861086.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,718 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1, which was entered into on 02/28/2023. Read SEC document |
| February 12, 2024 Filed Feb 13, 2024 21:54 UTC |
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
|
SaleCommon Stock | 913 | $420.24 | $383,679.12 |
DisclosureSEC source: 0000875320-24-000045 · wk-form4_1707861239.xml · nonDerivative · entry 2 Atkinson Edward Morrow III · CIK 0001914164 · EVP, Chief Technical Ops. Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,137 F1 · kind: Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 8/22/2023. Read SEC document |
| February 12, 2024 Filed Feb 13, 2024 21:56 UTC |
Biller JonathanEVP and Chief Legal Officer
|
SaleCommon Stock | 1,738 | $418.77 | $727,822.26 |
DisclosureSEC source: 0000875320-24-000047 · wk-form4_1707861402.xml · nonDerivative · entry 2 Biller Jonathan · CIK 0001744749 · EVP and Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,280 F1 · kind: Transaction made pursuant to Mr. Biller's company approved trading plan under Rule 10b5-1, which was entered into on 02/27/2023. F2 · price: Mr. Biller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $418.77 (range $418.76 to $418.82). Read SEC document |
| February 12, 2024 Filed Feb 13, 2024 22:15 UTC |
Sachdev AmitEVP Chief Patient & Ext Af Off
|
SaleCommon Stock | 3,222 | $420.24 | $1,354,013.28 |
DisclosureSEC source: 0000875320-24-000053 · wk-form4_1707862481.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · EVP Chief Patient & Ext Af Off 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,364 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2023. Read SEC document |
| February 12, 2024 Filed Feb 13, 2024 22:23 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
SaleCommon Stock | 314 | $420.24 | $131,955.36 |
DisclosureSEC source: 0000875320-24-000055 · wk-form4_1707862996.xml · nonDerivative · entry 2 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,179 F1 · kind: Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2023. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:04 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
SaleCommon Stock | 647 | $420.39 | $271,992.33 |
DisclosureSEC source: 0000875320-24-000059 · wk-form4_1707944646.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,644 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1, which was entered into on 08/04/2023. F2 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $420.39 (range $420.21 to $420.94). Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:04 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
SaleCommon Stock | 2,009 | $419.22 | $842,212.98 |
DisclosureSEC source: 0000875320-24-000059 · wk-form4_1707944646.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,291 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1, which was entered into on 08/04/2023. F2 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $419.22 (range $419.00 to $419.71). Read SEC document |
| February 09, 2024 Filed Feb 12, 2024 21:08 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
Tax withholdingCommon Stock | 8,048 | $422.74 | $3,402,211.52 |
DisclosureSEC source: 0000875320-24-000037 · wk-form4_1707772116.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,300 Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 21:48 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 591 | $422.74 | $249,839.34 |
DisclosureSEC source: 0000875320-24-000041 · wk-form4_1707860917.xml · nonDerivative · entry 1 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,050 Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 21:46 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Tax withholdingCommon Stock | 2,099 | $422.74 | $887,331.26 |
DisclosureSEC source: 0000875320-24-000039 · wk-form4_1707860733.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,733 Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 21:51 UTC |
Arbuckle Stuart AEVP, COO
|
Tax withholdingCommon Stock | 3,177 | $422.74 | $1,343,044.98 |
DisclosureSEC source: 0000875320-24-000043 · wk-form4_1707861086.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,013 Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 21:54 UTC |
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
|
Tax withholdingCommon Stock | 832 | $422.74 | $351,719.68 |
DisclosureSEC source: 0000875320-24-000045 · wk-form4_1707861239.xml · nonDerivative · entry 1 Atkinson Edward Morrow III · CIK 0001914164 · EVP, Chief Technical Ops. Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,050 Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 21:56 UTC |
Biller JonathanEVP and Chief Legal Officer
|
Tax withholdingCommon Stock | 1,588 | $422.74 | $671,311.12 |
DisclosureSEC source: 0000875320-24-000047 · wk-form4_1707861402.xml · nonDerivative · entry 1 Biller Jonathan · CIK 0001744749 · EVP and Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,018 Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 22:01 UTC |
Bozic CarmenEVP and CMO
|
Tax withholdingCommon Stock | 2,100 | $422.74 | $887,754.00 |
DisclosureSEC source: 0000875320-24-000049 · wk-form4_1707861651.xml · nonDerivative · entry 1 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,810 Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 22:07 UTC |
Kewalramani ReshmaDirector · CEO & President
|
Tax withholdingCommon Stock | 8,255 | $422.74 | $3,489,718.70 |
DisclosureSEC source: 0000875320-24-000051 · wk-form4_1707862030.xml · nonDerivative · entry 1 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,271 Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 22:15 UTC |
Sachdev AmitEVP Chief Patient & Ext Af Off
|
Tax withholdingCommon Stock | 2,022 | $422.74 | $854,780.28 |
DisclosureSEC source: 0000875320-24-000053 · wk-form4_1707862481.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP Chief Patient & Ext Af Off 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 77,586 Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 22:23 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
Tax withholdingCommon Stock | 2,100 | $422.74 | $887,754.00 |
DisclosureSEC source: 0000875320-24-000055 · wk-form4_1707862996.xml · nonDerivative · entry 1 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,493 Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 22:34 UTC |
WAGNER CHARLES F JREVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 2,607 | $422.74 | $1,102,083.18 |
DisclosureSEC source: 0000875320-24-000057 · wk-form4_1707863641.xml · nonDerivative · entry 1 WAGNER CHARLES F JR · CIK 0001223348 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,454 Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:08 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
Tax withholdingCommon Stock | 2,698 | $421.73 | $1,137,827.54 |
DisclosureSEC source: 0000875320-24-000037 · wk-form4_1707772116.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,348 Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 21:10 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
GrantCommon Stock | 7,114 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000014 · wk-form4_1707426599.xml · nonDerivative · entry 3 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,832 F3 · shares: Restricted stock unit award that vests in installments beginning on 02/17/2025. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 21:20 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
GrantCommon Stock | 1,853 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000016 · wk-form4_1707427226.xml · nonDerivative · entry 2 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,641 F2 · shares: Restricted stock unit award that vests in installments beginning on 02/17/2025. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 21:23 UTC |
Arbuckle Stuart AEVP, COO
|
GrantCommon Stock | 8,448 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000018 · wk-form4_1707427370.xml · nonDerivative · entry 3 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,190 F3 · shares: Restricted stock unit award that vests in installments beginning on 02/17/2025. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 21:24 UTC |
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
|
GrantCommon Stock | 4,743 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000020 · wk-form4_1707427484.xml · nonDerivative · entry 3 Atkinson Edward Morrow III · CIK 0001914164 · EVP, Chief Technical Ops. Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,882 F3 · shares: Restricted stock unit award that vests in installments beginning on 02/17/2025. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 21:28 UTC |
Biller JonathanEVP and Chief Legal Officer
|
GrantCommon Stock | 4,743 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000022 · wk-form4_1707427717.xml · nonDerivative · entry 2 Biller Jonathan · CIK 0001744749 · EVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,606 F2 · shares: Restricted stock unit award that vests in installments beginning on 02/17/2025. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 21:33 UTC |
Bozic CarmenEVP and CMO
|
GrantCommon Stock | 5,928 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000024 · wk-form4_1707427972.xml · nonDerivative · entry 3 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,910 F3 · shares: Restricted stock unit award that vests in installments beginning on 02/17/2025. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 21:38 UTC |
Kewalramani ReshmaDirector · CEO & President
|
GrantCommon Stock | 20,327 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000026 · wk-form4_1707428268.xml · nonDerivative · entry 3 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,526 F3 · shares: Restricted stock unit award that vests in installments beginning on 02/17/2025. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 21:40 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
GrantCommon Stock | 7,707 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000028 · wk-form4_1707428432.xml · nonDerivative · entry 3 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,046 F3 · shares: Restricted stock unit award that fully vested upon grant. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 21:43 UTC |
Sachdev AmitEVP Chief Patient & Ext Af Off
|
GrantCommon Stock | 7,114 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000030 · wk-form4_1707428580.xml · nonDerivative · entry 3 Sachdev Amit · CIK 0001406338 · EVP Chief Patient & Ext Af Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,608 F3 · shares: Restricted stock unit award that vests in installments beginning on 02/17/2025. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 21:45 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
GrantCommon Stock | 7,114 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000032 · wk-form4_1707428720.xml · nonDerivative · entry 3 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,593 F3 · shares: Restricted stock unit award that vests in installments beginning on 02/17/2025. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 21:47 UTC |
WAGNER CHARLES F JREVP & Chief Financial Officer
|
GrantCommon Stock | 7,114 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000034 · wk-form4_1707428861.xml · nonDerivative · entry 3 WAGNER CHARLES F JR · CIK 0001223348 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,061 F3 · shares: Restricted stock unit award that vests in installments beginning on 02/17/2025. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:10 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
GrantCommon Stock | 7,866 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000014 · wk-form4_1707426599.xml · nonDerivative · entry 2 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,718 F2 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest in installments beginning on 02/10/2024. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:10 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
GrantCommon Stock | 5,814 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000014 · wk-form4_1707426599.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,852 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2021 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest on 02/20/2024. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:20 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
GrantCommon Stock | 2,950 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000016 · wk-form4_1707427226.xml · nonDerivative · entry 1 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,788 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest in installments beginning on 02/10/2024. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:23 UTC |
Arbuckle Stuart AEVP, COO
|
GrantCommon Stock | 11,210 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000018 · wk-form4_1707427370.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,742 F2 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest in installments beginning on 02/10/2024. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:23 UTC |
Arbuckle Stuart AEVP, COO
|
GrantCommon Stock | 6,976 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000018 · wk-form4_1707427370.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,532 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2021 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest on 02/20/2024. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:24 UTC |
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
|
GrantCommon Stock | 3,934 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000020 · wk-form4_1707427484.xml · nonDerivative · entry 2 Atkinson Edward Morrow III · CIK 0001914164 · EVP, Chief Technical Ops. Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,139 F2 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest in installments beginning on 02/10/2024. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:24 UTC |
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
|
GrantCommon Stock | 2,326 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000020 · wk-form4_1707427484.xml · nonDerivative · entry 1 Atkinson Edward Morrow III · CIK 0001914164 · EVP, Chief Technical Ops. Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,205 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2021 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest on 02/20/2024. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:28 UTC |
Biller JonathanEVP and Chief Legal Officer
|
GrantCommon Stock | 6,294 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000022 · wk-form4_1707427717.xml · nonDerivative · entry 1 Biller Jonathan · CIK 0001744749 · EVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,863 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest in installments beginning on 02/10/2024. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:33 UTC |
Bozic CarmenEVP and CMO
|
GrantCommon Stock | 7,866 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000024 · wk-form4_1707427972.xml · nonDerivative · entry 2 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,982 F2 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest in installments beginning on 02/10/2024. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:33 UTC |
Bozic CarmenEVP and CMO
|
GrantCommon Stock | 5,814 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000024 · wk-form4_1707427972.xml · nonDerivative · entry 1 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,116 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2021 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest on 02/20/2024. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:38 UTC |
Kewalramani ReshmaDirector · CEO & President
|
GrantCommon Stock | 26,972 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000026 · wk-form4_1707428268.xml · nonDerivative · entry 2 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,199 F2 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest in installments beginning on 02/10/2024. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:38 UTC |
Kewalramani ReshmaDirector · CEO & President
|
GrantCommon Stock | 14,516 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000026 · wk-form4_1707428268.xml · nonDerivative · entry 1 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,227 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2021 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest on 02/20/2024. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:40 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
GrantCommon Stock | 20,452 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000028 · wk-form4_1707428432.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,339 F2 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest on 02/10/2024. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:40 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
GrantCommon Stock | 10,464 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000028 · wk-form4_1707428432.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,887 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2021 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest on 02/20/2024. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:43 UTC |
Sachdev AmitEVP Chief Patient & Ext Af Off
|
GrantCommon Stock | 7,866 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000030 · wk-form4_1707428580.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · EVP Chief Patient & Ext Af Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,494 F2 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest in installments beginning on 02/10/2024. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:43 UTC |
Sachdev AmitEVP Chief Patient & Ext Af Off
|
GrantCommon Stock | 5,814 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000030 · wk-form4_1707428580.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP Chief Patient & Ext Af Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,628 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2021 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest on 02/20/2024. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:45 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
GrantCommon Stock | 7,866 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000032 · wk-form4_1707428720.xml · nonDerivative · entry 2 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,479 F2 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest in installments beginning on 02/10/2024. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:45 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
GrantCommon Stock | 6,976 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000032 · wk-form4_1707428720.xml · nonDerivative · entry 1 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,613 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2021 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest on 02/20/2024. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:47 UTC |
WAGNER CHARLES F JREVP & Chief Financial Officer
|
GrantCommon Stock | 9,440 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-24-000034 · wk-form4_1707428861.xml · nonDerivative · entry 2 WAGNER CHARLES F JR · CIK 0001223348 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,947 F2 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest in installments beginning on 02/10/2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.